Collectively this data suggests that PKD2 plays an essential role in not only IL-35 expression by B cells, but also effector T cell function and ultimately regulates balance of tolerogenic and anti-tumor immunity in pancreatic tumor growth. This evidence concerns the gene PKD2 and neoplasm.